Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC29128959;8960;8961 chr2:178769847;178769846;178769845chr2:179634574;179634573;179634572
N2AB29128959;8960;8961 chr2:178769847;178769846;178769845chr2:179634574;179634573;179634572
N2A29128959;8960;8961 chr2:178769847;178769846;178769845chr2:179634574;179634573;179634572
N2B28668821;8822;8823 chr2:178769847;178769846;178769845chr2:179634574;179634573;179634572
Novex-128668821;8822;8823 chr2:178769847;178769846;178769845chr2:179634574;179634573;179634572
Novex-228668821;8822;8823 chr2:178769847;178769846;178769845chr2:179634574;179634573;179634572
Novex-329128959;8960;8961 chr2:178769847;178769846;178769845chr2:179634574;179634573;179634572

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCC
  • RefSeq wild type template codon: AGG
  • Domain: Ig-19
  • Domain position: 31
  • Structural Position: 46
  • Q(SASA): 0.1872
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/F None None 0.971 N 0.746 0.569 0.693576915185 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0569 likely_benign 0.0546 benign -0.719 Destabilizing 0.006 N 0.273 neutral N 0.455608119 None None N
S/C 0.2467 likely_benign 0.2062 benign -0.372 Destabilizing 0.992 D 0.722 prob.delet. N 0.518417153 None None N
S/D 0.9847 likely_pathogenic 0.976 pathogenic -0.677 Destabilizing 0.978 D 0.619 neutral None None None None N
S/E 0.984 likely_pathogenic 0.9741 pathogenic -0.594 Destabilizing 0.86 D 0.604 neutral None None None None N
S/F 0.8946 likely_pathogenic 0.8156 pathogenic -0.72 Destabilizing 0.971 D 0.746 deleterious N 0.461663826 None None N
S/G 0.2866 likely_benign 0.2483 benign -1.02 Destabilizing 0.559 D 0.588 neutral None None None None N
S/H 0.9577 likely_pathogenic 0.942 pathogenic -1.358 Destabilizing 0.998 D 0.723 prob.delet. None None None None N
S/I 0.8749 likely_pathogenic 0.7807 pathogenic 0.007 Stabilizing 0.956 D 0.719 prob.delet. None None None None N
S/K 0.9968 likely_pathogenic 0.9944 pathogenic -0.708 Destabilizing 0.86 D 0.596 neutral None None None None N
S/L 0.595 likely_pathogenic 0.4789 ambiguous 0.007 Stabilizing 0.754 D 0.653 neutral None None None None N
S/M 0.7769 likely_pathogenic 0.6839 pathogenic 0.008 Stabilizing 0.998 D 0.725 prob.delet. None None None None N
S/N 0.9011 likely_pathogenic 0.8632 pathogenic -0.809 Destabilizing 0.978 D 0.631 neutral None None None None N
S/P 0.8511 likely_pathogenic 0.7773 pathogenic -0.202 Destabilizing 0.971 D 0.716 prob.delet. N 0.517278567 None None N
S/Q 0.9715 likely_pathogenic 0.957 pathogenic -0.73 Destabilizing 0.978 D 0.676 prob.neutral None None None None N
S/R 0.9914 likely_pathogenic 0.9874 pathogenic -0.776 Destabilizing 0.956 D 0.721 prob.delet. None None None None N
S/T 0.3333 likely_benign 0.2599 benign -0.683 Destabilizing 0.822 D 0.585 neutral N 0.501207226 None None N
S/V 0.6479 likely_pathogenic 0.5265 ambiguous -0.202 Destabilizing 0.754 D 0.66 neutral None None None None N
S/W 0.9643 likely_pathogenic 0.9369 pathogenic -0.902 Destabilizing 0.998 D 0.748 deleterious None None None None N
S/Y 0.882 likely_pathogenic 0.8053 pathogenic -0.572 Destabilizing 0.99 D 0.751 deleterious N 0.487535914 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.